eNews
Home page > Comments


Comments

QLT's experimental eye drug could be worth up to $750 million

11.12.2012. | (Reuters) - Canadian eye drug developer QLT Inc expects its synthetic retinoid program, an experimental treatment for some inherited eye diseases that can cause blindness, to be valued at up to $750 million....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: